Life ScienceCompany
Sarepta Therapeutics M&A Summary
Sarepta Therapeutics has acquired 1 company, including 1 in the last 5 years.
Sarepta Therapeutics’ largest acquisition to date was in 2019, when it acquired Myonexus Therapeutics for $165M. Sarepta Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Sarepta Therapeutics Business Overview
Where is Sarepta Therapeutics headquartered?
Sarepta Therapeutics is headquartered in Cambridge, Massachusetts.
What is Sarepta Therapeutics’ revenue?
Sarepta Therapeutics disclosed revenue of 1,243M USD for 2023 and 933M USD for 2022.
How many employees does Sarepta Therapeutics have?
Sarepta Therapeutics has 1,314 employees.
What sector is Sarepta Therapeutics in?
Sarepta Therapeutics is a life science company.
When was Sarepta Therapeutics founded?
Sarepta Therapeutics was founded in 1980.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1